RxDoctor Payments Data

Emma Nauman

Psychiatric/Mental Health · Seattle, WANPI 1093287120

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,491 and has fallen 86.8% since, to $197 in 2025. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,084in general payments, 2019–2025

Across 174 payments — averaging $23.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$738
  • Otsuka America Pharmaceutical, Inc.$606
  • Vanda Pharmaceuticals Inc.$338
  • Supernus Pharmaceuticals, Inc.$324
  • Sage Therapeutics, LLC$258
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$245
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$4,02999%
  • Education$551%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,084 in reported general payments places this provider in the 90th percentile of 931 psychiatric/mental health providers in Washington.

See all psychiatric/mental health providers in Washington

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mirtazapine13$75

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →